Iridian Asset Management LLC Bridge Bio Pharma, Inc. Transaction History

Iridian Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$46.87 - $64.24 $46 Million - $63.1 Million	-982,464 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$46.47 - $63.93 $1.89 Million - $2.59 Million	-40,570 Reduced 3.97%	982,464 $59.9 Million
Q1 2021 May 11, 2021	BUY	$55.47 - $72.35 $26.6 Million - $34.6 Million	478,907 Added 88.01%	1,023,034 $63 Million
Q4 2020 Feb 08, 2021	BUY	$38.38 - $71.11 $20.9 Million - $38.7 Million	544,127 New	544,127 $38.7 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Iridian Asset Management LLC with notifications on news.